To view the PDF file, sign up for a MySharenet subscription.

NETWORK HEALTHCARE HOLDINGS LIMITED - TRADING STATEMENT

Release Date: 12/11/2004 08:00
Code(s): NTC
Wrap Text

NETWORK HEALTHCARE HOLDINGS LIMITED - TRADING STATEMENT NETWORK HEALTHCARE HOLDINGS LIMITED (Registration number 1996/008242/06) Code: NTC ISIN number: ZAE000011953 ("Netcare" or "the Group") TRADING STATEMENT Shareholders are advised that even though the circumstances giving rise to this announcement do not warrant the publication of a trading statement in terms of the JSE Securities Exchange SA Listings Requirements, it has been deemed appropriate to provide the shareholders with the following information in anticipation of the release of the Netcare results for the year ending 30 September 2004. Following a preliminary analysis of the Group"s performance for the year ended 30 September 2004, shareholders are advised that notwithstanding satisfactory growth and activity in the Netcare Group"s core hospital and ancillary healthcare divisions, the results will be impacted by period-specific non recurring items and prior year adjustments, which are detailed below: Non recurring items As recorded in the interim results for the six months ended 31 March 2004 and subsequent presentations, * Netcare 911 experienced a once off charge of R26.9 million due to restructuring costs, cancellation of forex linked contracts and the discontinuation of loss making business units and products; and * The issue of 100 million Netcare shares to, and subsequent reinvestment in, Netpartner Investments Limited on 30 September 2003 has had the predictable short-term dilutionary effect on headline earnings per share of approximately 3% for the period; Due to the volatility experienced in the politically sensitive Middle East, a strategic decision was made to discontinue all operations in that region. The Group has written off an amount of R22.7 million relating to associated costs in this accounting period. Since the introduction of the regulations applicable to single exit pricing on pharmaceuticals which were implemented on 1 May, the Group has been impacted negatively by a higher cost of drug purchases for the 4.5 months preceding successful renegotiation of tariffs with the funders. Prior year adjustments In terms of AC 133 (Financial Instruments - Recognition and Measurement) and AC 103 (Accounting Policies, Changes in accounting estimates and errors), prior year adjustments have been made for: * Financial Assets relating to the Netcare Trust * Supplier rebates Despite the aggregate effect of the prior year adjustments and non recurring items, the Group is nevertheless expected to record a positive growth in headline earnings per share for the year of approximately 5% to 15%. The financial information upon which this trading statement is based is in the process of being reviewed and reported on by the company"s auditors. Shareholders are advised that the results for the year ended 30 September 2004 are expected to be released on SENS on Wednesday, 17 November 2004. Sandton 12 November 2004 Sponsor Merrill Lynch South Africa (Pty) Limited Date: 12/11/2004 08:00:04 AM Supplied by www.sharenet.co.za Produced by the JSE SENS Department

Share This Story